Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Mitochondrial-encoded MOTS-c as novel therapeutic target in autoimmune diabetes

Sep. 15, 2021

vTv Therapeutics discloses glucokinase activators

Sep. 14, 2021

Lilly identifies new ketohexokinase inhibitors

Sep. 6, 2021

Thymic stromal lymphopoietin and T cells shown to homeostatically regulate sebum production

Sep. 3, 2021

International researchers discover first nonhormonal treatment target for endometriosis

Aug. 31, 2021

Gasherbrum Bio presents new GLP-1 receptor agonists

Aug. 30, 2021

Ultragenyx opens enrollment in adaptive study of UX-701 in Wilson's disease

Aug. 25, 2021

STING signaling identified as a therapeutic target for Niemann-Pick disease type C

Aug. 25, 2021

Lilly describes new GIPR and GLP-1 receptor agonists

Aug. 25, 2021

KalVista gains clinical trial approvals for phase II trial of KVD-824 for HAE

Aug. 23, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...